Emerging stem cell treatments have been heralded as revolutionary for medicine and biotechnology, but more research still needs to be done to utilize these cells for therapies. Many barriers still stand in the way of these studies: discussions over ethical issues surrounding the use of human embryonic stem cells; policy issues regarding science funding and regulation; and economic pressures. These factors affect federal and state policy on stem cell research.
Texas is one of many states that has no existing stem cell policy. In a recently published report, the International Stem Cell Policy Program, part of the Baker Institute Science and Technology Program, examines the current economic and political conditions that would affect stem cell policy in Texas. The authors highlight future potential for this area of research to have a positive impact on medicine and on the state.
Jan 19 2022 | Baker Institute
Gabriel Collins , Michelle Michot Foss
Jan 18 2022 | Center for Energy Studies